Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $6.83 | Prev. Close $6.91 | Circuit Range N/A |
Day Range $6.62 - $6.83 | Year Range $0.24 - $7.49 | Volume 42,356 |
Average Traded $6.69 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Apr-26 | $6.89 | $6.92 | -0.86% |
02-Apr-26 | $6.70 | $6.98 | -1.34% |
01-Apr-26 | $7.03 | $7.08 | +1.95% |
31-Mar-26 | $6.43 | $6.94 | +8.95% |
30-Mar-26 | $6.37 | $6.37 | -0.78% |
27-Mar-26 | $6.54 | $6.42 | -1.68% |
26-Mar-26 | $6.50 | $6.53 | -1.73% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?